Intravenous Immunomodulatory Nanoparticle Treatment for Traumatic Brain Injury.

Sripadh SharmaIgal IferganJonathan E KurzRobert A LinsenmeierDan XuJohn G CooperStephen D MillerJohn A Kessler

Published in: Annals of neurology (2020)

Our findings suggest that IMPs are a clinically translatable acute intervention for TBI with a well-defined mechanism of action and beneficial anatomic and physiologic preservation and recovery. Ann Neurol 2020;87:442-455.

Keyphrases

traumatic brain injury
liver failure
randomized controlled trial
respiratory failure
severe traumatic brain injury
drug induced
aortic dissection
combination therapy
intensive care unit